12/4
07:32 am
plrz
From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection
Medium
Report
From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection
12/3
09:53 am
plrz
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product [Yahoo! Finance]
Medium
Report
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product [Yahoo! Finance]
12/3
09:28 am
plrz
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product
Medium
Report
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product
12/2
06:14 pm
plrz
CNN values your feedback [CNN]
High
Report
CNN values your feedback [CNN]
11/6
09:22 am
plrz
Polyrizon Demonstrates Reversible Broad-Spectrum Viral Blocking by Its Intranasal Barrier-Forming Formulation [Yahoo! Finance]
Low
Report
Polyrizon Demonstrates Reversible Broad-Spectrum Viral Blocking by Its Intranasal Barrier-Forming Formulation [Yahoo! Finance]
11/6
08:55 am
plrz
Polyrizon Demonstrates Reversible Broad-Spectrum Viral Blocking by Its Intranasal Barrier-Forming Formulation
High
Report
Polyrizon Demonstrates Reversible Broad-Spectrum Viral Blocking by Its Intranasal Barrier-Forming Formulation
10/6
08:21 am
plrz
Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy
Low
Report
Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy
9/20
01:09 am
plrz
Low
Report
9/19
08:15 am
plrz
Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker
Medium
Report
Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker
9/12
07:26 am
plrz
Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study
High
Report
Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study